天美传媒

Abstract

Stomach cancer surgery has experienced significant advancements in recent years, driven by innovations in surgical techniques, technology, and personalized medicine. Minimally invasive approaches, such as laparoscopy and robotic-assisted surgery, offer reduced recovery times, enhanced precision, and lower complication risks. The integration of neoadjuvant therapies, which shrink tumors before surgery, improves surgical feasibility and outcomes. Advanced imaging techniques, including high-resolution endoscopy and PET-CT scans, enable more accurate preoperative planning and intraoperative guidance. Furthermore, personalized surgical strategies and improved postoperative care protocols are optimizing treatment efficacy and patient recovery. These innovations collectively represent a transformative shift in the management of stomach cancer, aiming to enhance surgical outcomes and overall patient well-being.